Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021; 71: 209–49. doi: <a href="https://doi.org/10.3322/caac.21660" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.3322/caac.21660</a>
Katai H, Ishikawa T, Akazawa K, Isobe Y, Miyashiro I, Oda I, et al. Five-year survival analysis of surgically resected gastric cancer cases in Japan: a retrospective analysis of more than 100,000 patients from the nationwide registry of the Japanese Gastric Cancer Association (2001–2007). Gastric Cancer 2018; 21: 144–54. doi: <a href="https://doi.org/10.1007/s10120-017-0716-7" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1007/s10120-017-0716-7</a>
Miyagawa K, Tsuruga T, Kinomura A, Usui K, Katsura M, Tashiro S, et al. A role for RAD54B in homologous recombination in human cells. Embo J 2002; 21: 175–80. doi: <a href="https://doi.org/10.1093/emboj/21.1.175" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1093/emboj/21.1.175</a>
Yasuhara T, Suzuki T, Katsura M, Miyagawa K. Rad54B serves as a scaffold in the DNA damage response that limits checkpoint strength. Nat Commun 2014; 5: 5426. doi: <a href="https://doi.org/10.1038/ncomms6426" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1038/ncomms6426</a>
Zhang Z, Li X, Han Y, Ji T, Huang X, Gao Q, et al. RAD54B potentiates tumor growth and predicts poor prognosis of patients with luminal A breast cancer. Biomed Pharmacother 2019; 118: 109341. doi: <a href="https://doi.org/10.1016/j.biopha.2019.109341" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/j.biopha.2019.109341</a>
Feng S, Liu J, Hailiang L, Wen J, Zhao Y, Li X, et al. Amplification of RAD54B promotes progression of hepatocellular carcinoma via activating the Wnt/β-catenin signaling. Transl Oncol 2021; 14: 101124. doi: <a href="https://doi.org/10.1016/j.tranon.2021.101124" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/j.tranon.2021.101124</a>
Xu C, Liu D, Mei H, Hu J, Luo M. Knockdown of RAD54B expression reduces cell proliferation and induces apoptosis in lung cancer cells. J Int Med Res 2019; 47: 5650–9. doi: <a href="https://doi.org/10.1177/0300060519869423" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1177/0300060519869423</a>
Nagai Y, Yamamoto Y, Yasuhara T, Hata K, Nishikawa T, Tanaka T, et al. High RAD54B expression: an independent predictor of postoperative distant recurrence in colorectal cancer patients. Oncotarget 2015; 6: 21064–73. doi: <a href="https://doi.org/10.18632/oncotarget.4222" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.18632/oncotarget.4222</a>
Tang Z, Kang B, Li C, Chen T, Zhang Z. GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res 2019; 47: W556–60. doi: <a href="https://doi.org/10.1093/nar/gkz430" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1093/nar/gkz430</a>
Wang M, Liao J, Tan C, Zhou H, Wang J, Wang K, et al. Integrated study of miR-215 promoting breast cancer cell apoptosis by targeting RAD54B. J Cell Mol Med 2021; 25: 3327–38. doi: <a href="https://doi.org/10.1111/jcmm.16402" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1111/jcmm.16402</a>
Wang R, Li Y, Chen Y, Wang L, Wu Q, Guo Y, et al. Inhibition of RAD54B suppresses proliferation and promotes apoptosis in hepatoma cells. Oncol Rep 2018; 40: 1233–42. doi: <a href="https://doi.org/10.3892/or.2018.6522" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.3892/or.2018.6522</a>
Katayama Y, Uchino J, Chihara Y, Tamiya N, Kaneko Y, Yamada T, et al. Tumor neovascularization and developments in therapeutics. Cancers 2019; 11. doi: <a href="https://doi.org/10.3390/cancers11030316" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.3390/cancers11030316</a>
Chatterjee A, Paul S, Bisht B, Bhattacharya S, Sivasubramaniam S, Paul MK. Advances in targeting the WNT/β-catenin signaling pathway in cancer. Drug Discov Today 2022; 27: 82–101. doi: <a href="https://doi.org/10.1016/j.drudis.2021.07.007" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/j.drudis.2021.07.007</a>
Li TH, Zhao BB, Qin C, Wang YY, Li ZR, Cao HT, et al. IFIT1 modulates the proliferation, migration and invasion of pancreatic cancer cells via Wnt/β-catenin signaling. Cell Oncol 2021; 44: 1425–37. doi: <a href="https://doi.org/10.1007/s13402-021-00651-8" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1007/s13402-021-00651-8</a>
Xueqin T, Jinhong M, Yuping H. Inhibin subunit beta A promotes cell proliferation and metastasis of breast cancer through Wnt/β-catenin signaling pathway. Bioengineered 2021; 12: 11567–75. doi: <a href="https://doi.org/10.1080/21655979.2021.1971028" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1080/21655979.2021.1971028</a>
Yan Y, Zhang Y, Li M, Zhang Y, Zhang X, Zhang X, et al. C644-0303, a small-molecule inhibitor of the Wnt/β-catenin pathway, suppresses colorectal cancer growth. Cancer Sci 2021; 112: 4722–35. doi: <a href="https://doi.org/10.1111/cas.15118" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1111/cas.15118</a>
Song X, Wang S, Li L. New insights into the regulation of Axin function in canonical Wnt signaling pathway. Protein Cell 2014; 5: 186–93. doi: <a href="https://doi.org/10.1007/s13238-014-0019-2" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1007/s13238-014-0019-2</a>
Brabletz T, Jung A, Dag S, Hlubek F, Kirchner T. beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer. Am J Pathol 1999; 155: 1033–8. doi: <a href="https://doi.org/10.1016/s0002-9440(10)65204-2" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/s0002-9440(10)65204-2</a>